|

Zuberitamab Clinical Trials

1 actively recruiting trial

Also known as: Induction phase, Maintenance phase

Top Sponsors

  • Peking University Third Hospital1

Indications

  • POZ1
  • Mantle Cell Lymphoma (MCL)1
  • Cancer1

Other1 trial

Pomalidomide Plus Orelabrutinib and Zuberitamab in Untreated Mantle Cell Lymphoma
N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.